News
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback